Introduction
TB-500 is a synthetic version of a naturally occurring fragment of thymosin beta-4 (Tβ4), a 43-amino-acid protein found in nearly all mammalian cells. In laboratory research, TB-500 is primarily of interest for its role in actin regulation — the process by which cells build and reorganise their internal skeleton.
What does the research focus on?
Thymosin beta-4 binds to G-actin monomers, influencing how cells migrate, differentiate and respond to injury signals in vitro. Published preclinical work has explored Tβ4 in models of:
- Cell migration studies — Tβ4 upregulation is consistently observed at sites of tissue remodelling in animal models.
- Angiogenesis research — several rodent studies have examined new blood-vessel formation in the presence of Tβ4 fragments.
- Cardiac tissue models — Tβ4 attracted attention after studies in mice examined cardiomyocyte survival following ischaemic injury.
- Corneal and dermal wound models — among the earliest and most cited areas of Tβ4 investigation.
The central active region of the molecule — the actin-binding domain — is the segment reproduced in TB-500, which is why researchers often treat the two terms as closely related in the literature.
TB-500 and BPC-157 in research
TB-500 is frequently studied alongside BPC-157, as both appear in preclinical tissue-repair literature but act through entirely different mechanisms — BPC-157 is a gastric pentadecapeptide, while TB-500 works on the actin cytoskeleton. Our article on BPC-157 and TB-500 covers the comparison in depth.
Quality considerations for researchers
Because TB-500 is a longer synthetic peptide, synthesis quality matters. Reputable suppliers provide batch-specific HPLC and mass-spectrometry verification. Every vial of TB-500 supplied by BioSupply UK ships with a Certificate of Analysis confirming ≥99% purity.
Summary
TB-500 remains one of the most requested compounds in peptide research, with a preclinical literature base spanning cell migration, angiogenesis and tissue-model studies. Human clinical evidence remains limited, and the compound is not approved for therapeutic use anywhere in the world.
All products mentioned are supplied strictly for laboratory research purposes only and are not intended for human consumption, diagnosis, or treatment. Nothing in this article constitutes medical advice.